The multifaceted role of lemur tyrosine kinase 3 in health and disease |
| |
Authors: | Angeliki Ditsiou Teresa Gagliano Mark Samuels Viviana Vella Christos Tolias Georgios Giamas |
| |
Affiliation: | 1. Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, JMS Building, Falmer, Brighton BN1 9QG, UK ; 2. Department of Medicine, University of Udine, Piazzale Kolbe 4, Udine 33100, Italy ; 3. Department of Neurosurgery, Royal Sussex County Hospital, Brighton and Sussex University Hospitals (BSUH) NHS Trust, Millennium Building, Brighton BN2 5BE, UK |
| |
Abstract: | In the last decade, LMTK3 (lemur tyrosine kinase 3) has emerged as an important player in breast cancer, contributing to the advancement of disease and the acquisition of resistance to therapy through a strikingly complex set of mechanisms. Although the knowledge of its physiological function is largely limited to receptor trafficking in neurons, there is mounting evidence that LMTK3 promotes oncogenesis in a wide variety of cancers. Recent studies have broadened our understanding of LMTK3 and demonstrated its importance in numerous signalling pathways, culminating in the identification of a potent and selective LMTK3 inhibitor. Here, we review the roles of LMTK3 in health and disease and discuss how this research may be used to develop novel therapeutics to advance cancer treatment. |
| |
Keywords: | LMTK3 protein kinase CNS cancer small molecule kinase inhibitor |
|
|